Management Change15 Jul 2026, 05:30 pm
Shilpa Biologicals CEO Resigns Due to Personal Commitments
AI Summary
Dr. Sridevi Khambhampaty has resigned as the Chief Executive Officer (CEO) of Shilpa Biologicals Private Limited, a material subsidiary of Shilpa Medicare Limited. Her resignation is effective from the closing hours of July 15, 2026, citing personal commitments. The company has provided the requisite disclosure as per SEBI regulations. Dr. Khambhampaty expressed gratitude for the opportunity and wished the company continued success.
Key Highlights
- CEO of Shilpa Biologicals Private Limited resigns.
- Resignation is effective July 15, 2026.
- Reason cited is personal commitments.
- Disclosure made as per SEBI regulations.
Price Impact
More from SHILPAMED